American Osteopathic Association Prolotherapy Regenerative Medicine
EIN: 751171583 · Middletown, DE · NTEE: H03
| Metric | Value |
|---|---|
| Total Revenue | $153K |
| Total Expenses | $63K |
| Net Assets | $152K |
Is American Osteopathic Association Prolotherapy Regenerative Medicine Legit?
Insufficient Data
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
About American Osteopathic Association Prolotherapy Regenerative Medicine
American Osteopathic Association Prolotherapy Regenerative Medicine (EIN: 751171583) is a nonprofit organization based in Middletown, DE, classified under NTEE code H03. The organization reported total revenue of $153K and total assets of $134K according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of American Osteopathic Association Prolotherapy Regenerative Medicine's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
American Osteopathic Association Prolotherapy Regenerative Medicine is a small nonprofit that has been operating for 60 years, with 14 years of IRS 990 filings on record (2011–2024). Revenue has grown at a compound annual rate of -5.6%.
Key Financial Metrics (2024)
From the most recent IRS 990 filing on record:
| Total Revenue | $31K |
| Total Expenses | $63K |
| Surplus / Deficit | $-31,369 |
| Total Assets | $155K |
| Total Liabilities | $2K |
| Net Assets | $152K |
| Operating Margin | -100.2% |
| Debt-to-Asset Ratio | 1.4% |
| Months of Reserves | 29.6 months |
Financial Health Grade: B
In 2024, American Osteopathic Association Prolotherapy Regenerative Medicine reported a deficit of $31K with expenses exceeding revenue, holds 29.6 months of operating reserves (strong position), has a debt-to-asset ratio of 1.4% (very low leverage).
Financial Trends
Over 14 years of filings (2011–2024), American Osteopathic Association Prolotherapy Regenerative Medicine's revenue has declined at a compound annual growth rate (CAGR) of -5.6%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2024 | -50.9% | +32.1% | -16.5% |
| 2023 | +81.4% | -5.9% | +3.0% |
| 2022 | -9.0% | -11.0% | -6.7% |
| 2021 | -32.8% | -2.4% | -8.7% |
| 2020 | -39.3% | -8.3% | +4.1% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 2000 |
| IRS Ruling Date | 1966 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Analysis Pending
AI enrichment for American Osteopathic Association Prolotherapy Regenerative Medicine has not yet been completed. Basic IRS 990 data is shown below. Check back later for a full transparency report including a Mission Score, spending breakdown, executive compensation analysis, and red flags assessment.
Mission Effectiveness Score
NonprofitSpending's AI analysis rates American Osteopathic Association Prolotherapy Regenerative Medicine with a Mission Score of 0 out of 100 (Very Poor). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Key Financial Metrics (2024)
From the most recent IRS 990 filing on record:
- The organization reported a deficit of $31K, with expenses exceeding revenue.
- Debt-to-asset ratio: 1.4%.
Frequently Asked Questions about American Osteopathic Association Prolotherapy Regenerative Medicine
Is American Osteopathic Association Prolotherapy Regenerative Medicine a legitimate charity?
American Osteopathic Association Prolotherapy Regenerative Medicine (EIN: 751171583) is a registered tax-exempt nonprofit based in Delaware. It has 14 years of IRS 990 filings on record. Total revenue: $153K. No red flags identified. Financial health grade: B.
How does American Osteopathic Association Prolotherapy Regenerative Medicine spend its money?
American Osteopathic Association Prolotherapy Regenerative Medicine reported $153K in total revenue in IRS 990 filings. 14 years of filing data available. Expenses exceeded revenue in the most recent year. Review the full spending breakdown on NonprofitSpending.
Are donations to American Osteopathic Association Prolotherapy Regenerative Medicine tax-deductible?
American Osteopathic Association Prolotherapy Regenerative Medicine is registered as a tax-exempt nonprofit (EIN: 751171583). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
Where is American Osteopathic Association Prolotherapy Regenerative Medicine located?
American Osteopathic Association Prolotherapy Regenerative Medicine is headquartered in Middletown, Delaware and files with the IRS under EIN 751171583. It is classified under NTEE code H03.
How many years of IRS 990 filings does American Osteopathic Association Prolotherapy Regenerative Medicine have?
American Osteopathic Association Prolotherapy Regenerative Medicine has 14 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $153K in total revenue.
Filing History
IRS 990 filing history for American Osteopathic Association Prolotherapy Regenerative Medicine showing financial trends over 14 years of public records:
Over 14 years of IRS 990 filings (2011–2024), American Osteopathic Association Prolotherapy Regenerative Medicine's revenue has declined by 53%, moving from $67K to $31K. Total assets increased by 45.3% over the same period, from $106K to $155K. Total functional expenses rose by 21.7%, from $51K to $63K. In its most recent filing year (2024), American Osteopathic Association Prolotherapy Regenerative Medicine reported a deficit of $31K, with expenses exceeding revenue. The organization holds $2K in liabilities against $155K in assets (debt-to-asset ratio: 1.4%), resulting in net assets of $152K.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2024 | $31K | $63K | $155K | $2K | — | — |
| 2023 | $64K | $47K | $185K | $1K | — | View 990 |
| 2022 | $35K | $50K | $180K | $12K | — | View 990 |
| 2021 | $39K | $57K | $193K | $10K | — | — |
| 2020 | $57K | $58K | $211K | $10K | — | View 990 |
| 2019 | $95K | $63K | $203K | $1K | — | View 990 |
| 2018 | $96K | $59K | $171K | $1K | — | — |
| 2017 | $52K | $58K | $133K | $1K | — | View 990 |
| 2016 | $125K | $60K | $141K | $1K | — | View 990 |
| 2015 | $43K | $58K | $70K | $1K | — | View 990 |
| 2014 | $67K | $49K | $95K | $930 | — | View 990 |
| 2013 | $39K | $57K | $73K | $760 | — | View 990 |
| 2012 | $62K | $52K | $104K | $709 | — | View 990 |
| 2011 | $67K | $51K | $106K | $709 | — | View 990 |
Year-by-Year Financial Summary
- 2024: Revenue of $31K, expenses of $63K, and assets of $155K (revenue -50.9% year-over-year).
- 2023: Revenue of $64K, expenses of $47K, and assets of $185K (revenue +81.4% year-over-year).
- 2022: Revenue of $35K, expenses of $50K, and assets of $180K (revenue -9.0% year-over-year).
- 2021: Revenue of $39K, expenses of $57K, and assets of $193K (revenue -32.8% year-over-year).
- 2020: Revenue of $57K, expenses of $58K, and assets of $211K (revenue -39.3% year-over-year).
- 2019: Revenue of $95K, expenses of $63K, and assets of $203K (revenue -1.4% year-over-year).
- 2018: Revenue of $96K, expenses of $59K, and assets of $171K (revenue +86.1% year-over-year).
- 2017: Revenue of $52K, expenses of $58K, and assets of $133K (revenue -58.8% year-over-year).
- 2016: Revenue of $125K, expenses of $60K, and assets of $141K (revenue +190.7% year-over-year).
- 2015: Revenue of $43K, expenses of $58K, and assets of $70K (revenue -35.8% year-over-year).
- 2014: Revenue of $67K, expenses of $49K, and assets of $95K (revenue +70.9% year-over-year).
- 2013: Revenue of $39K, expenses of $57K, and assets of $73K (revenue -36.5% year-over-year).
- 2012: Revenue of $62K, expenses of $52K, and assets of $104K (revenue -7.3% year-over-year).
- 2011: Revenue of $67K, expenses of $51K, and assets of $106K.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for American Osteopathic Association Prolotherapy Regenerative Medicine:
Data Sources and Methodology
This transparency report for American Osteopathic Association Prolotherapy Regenerative Medicine is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.